国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
益心舒胶囊对60例胸痹患者血液流变学影响
Hemorheological Efficacy of Yixinshu Capsule in Treating 60 Chest-spleen-syndrome Patients
投稿时间:2007-04-16  修订日期:2007-06-08
DOI:
中文关键词:  益心舒  胸痹  血液流变学
英文关键词:Yixinshu,Chest-spleen-syndrome,Hemorheology
基金项目:
钱越洲  刘宇  朱利民
上海中医药大学附属龙华医院 (上海200032)
摘要点击次数: 1551
全文下载次数: 110
中文摘要:
      目的:观察及评估益心舒胶囊对气阴两虚或兼血瘀胸痹患者的血液流变学的影响。方法:按照冠心病的诊断标准,气阴两虚或兼血瘀的胸痹入选标准,自2006年1月~2007年2月收集门诊及住院患者60例,服用益心舒胶囊4粒,tid,服用4周,前后对照观察血液流变学的改变及血常规的改变。结果:益心舒胶囊能改善血液流变学各项指标(P<0.05),降低血黏度,对血常规的各种血细胞数量无影响(P>0.05)。结论:益心舒胶囊能治疗胸痹患者,有临床推广意义。
英文摘要:
      Objective:To observe and assess the hemorheological efficacy of yixinshu capsules in the treatment of"deficiency of both vital energy and yin or blood stasis"chest-spleen-syndrome patients.Method:According to the stand- ard of the diagnosis of coronary heart diseases and deficiency of both vital energy and yin or blood stasis chest-bi-syndrome, 60 cases were collected from Jan.2006 to Feb.2007 in ward and clinic.Each case was treated with yixinshu capsule for four weeks and its hemorheological efficacy and routine blood change were observed and compared before and after the treat- ment.Result:The yixinshu capsules improved various hemorheological indexes more significantly after the treatment than before it (P<0.05),but did not have any effect on the blood celluar count (P>0.05).Conclusion:Yixinshu capsules are an effective medicine for the chest-spleen-syndrome case,and recommendable for clinical treatment.
查看全文  查看/发表评论  下载PDF阅读器
关闭